Evidence map›Paper›PMID 19855391›Full record

ArticleNature methods2009

'Edgetic' perturbation of a C. elegans BCL2 ortholog.

Matija Dreze, Benoit Charloteaux, Stuart Milstein, Pierre-Olivier Vidalain, Muhammed A Yildirim, Quan Zhong, Nenad Svrzikapa, Viviana Romero, Géraldine Laloux, Robert Brasseur and 5 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature methods, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cell Death in C. elegans Development.Current topics in developmental biology · 2015
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Edgotype: a fundamental link between genotype and phenotype.Current opinion in genetics & development · 2013
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Matija DrezeCenter for Cancer Systems Biology (CCSB) and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Benoit Charloteaux
Stuart Milstein
Pierre-Olivier Vidalain
Muhammed A Yildirim
Quan Zhong
Nenad Svrzikapa
Viviana Romero
Géraldine Laloux
Robert Brasseur
Jean Vandenhaute
Mike Boxem
Michael E Cusick
David E Hill
Marc Vidal
Dana-Farber Cancer Institute · USCentre National de la Recherche Scientifique · FRUniversity of Namur · BEGembloux Agro-Bio Tech · BE

Funding

The C. elegans Interactome ProjectR01HG001715 · NHGRI · MASSACHUSETTS GENERAL HOSPITAL · PI HILL, DAVID E., ROTH, FREDERICK P · 1998 to 2010
$16.5M
Tumor Cell Biology Training ProgramT32CA009361 · NCI · DANA-FARBER CANCER INSTITUTE · PI GRAY, NATHANAEL SCHIANDER · 1985 to 2015
$8.9M
Systems Analysis of Cancer Pathways in Mouse ModelsU01CA105423 · NCI · DANA-FARBER CANCER INSTITUTE · PI ORKIN, STUART H · 2004 to 2013
$8.4M
Integrated interactome mappingR33CA105405 · NCI · DANA-FARBER CANCER INSTITUTE · PI VIDAL, MARC · 2004 to 2006
$2.0M
Application of Technologies for Interactome Network Analyses of Cancer MutationsR33CA132073 · NCI · DANA-FARBER CANCER INST · PI VIDAL, MARC · 2008 to 2010
$1.8M
NEW TECHNOLOGIES FOR PROTEIN INTERACTION MAPPINGR33CA081658 · NCI · DANA-FARBER CANCER INSTITUTE · PI VIDAL, MARC · 2000 to 2002
$1.7M
NEW TECHNOLOGIES FOR PROTEIN INTERACTION MAPPINGR21CA081658 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI VIDAL, MARC · 1999 to 1999
–
Howard Hughes Medical InstituteNCI NIH HHS R21/R33 CA081658NCI NIH HHS R33 CA081658NCI NIH HHS R33 CA105405NCI NIH HHS R33 CA132073NCI NIH HHS T32 CA009361NCI NIH HHS T32CA09361NCI NIH HHS U01 CA105423NHGRI NIH HHS R01 HG001715
6 · The paper itself

Abstract

Genes and gene products do not function in isolation but within highly interconnected 'interactome' networks, modeled as graphs of nodes and edges representing macromolecules and interactions between them, respectively. We propose to investigate genotype-phenotype associations by methodical use of alleles that lack single interactions, while retaining all others, in contrast to genetic approaches designed to eliminate gene products completely. We describe an integrated strategy based on the reverse yeast two-hybrid system to isolate and characterize such edge-specific, or 'edgetic', alleles. We established a proof of concept with CED-9, a Caenorhabditis elegans BCL2 ortholog. Using ced-9 edgetic alleles, we uncovered a new potential functional link between apoptosis and a centrosomal protein. This approach is amenable to higher throughput and is particularly applicable to interactome network analysis in organisms for which transgenesis is straightforward.

Indexed as

AllelesAmino Acid SequenceAnimalsBinding SitesCaenorhabditis elegansCaenorhabditis elegans ProteinsCalcium-Binding ProteinsGenes, HelminthGenotypeModels, MolecularPhenotypeProtein Interaction MappingProto-Oncogene Proteins c-bcl-2Repressor ProteinsTwo-Hybrid System TechniquesCaenorhabditis elegans ProteinsCalcium-Binding ProteinsCed-4 protein, C elegansCed-9 protein, C elegansEGL-1 protein, C elegansProto-Oncogene Proteins c-bcl-2Repressor Proteins

Identifiers

PMID19855391
PMCPMC2865203
OpenAlexW2039568484

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.